|
MAGT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.18000003896435E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.49890000411546E-09 |
| Normal-vs-Stage2 |
3.191900E-04 |
| Normal-vs-Stage3 |
2.005200E-01 |
| Normal-vs-Stage4 |
6.244600E-03 |
| Stage1-vs-Stage2 |
5.611400E-01 |
| Stage1-vs-Stage3 |
4.408000E-02 |
| Stage1-vs-Stage4 |
6.428200E-01 |
| Stage2-vs-Stage3 |
1.885830E-01 |
| Stage2-vs-Stage4 |
4.062600E-01 |
| Stage3-vs-Stage4 |
1.256770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.98630001125144E-09 |
| Normal-vs-AfricanAmerican |
1.61555999999008E-05 |
| Normal-vs-Asian |
7.860800E-03 |
| Caucasian-vs-AfricanAmerican |
6.059200E-01 |
| Caucasian-vs-Asian |
9.676400E-01 |
| AfricanAmerican-vs-Asian |
8.848400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.72030192710804E-11 |
| Normal-vs-Female |
4.763800E-02 |
| Male-vs-Female |
6.17429999999475E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.51380000004797E-06 |
| Normal-vs-Extreme_Weight |
5.44639999766616E-10 |
| Normal-vs-Obese |
3.433700E-04 |
| Normal-vs-Extreme_Obese |
4.08390000000702E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.589800E-01 |
| Normal_Weight-vs-Obese |
1.688000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.950200E-01 |
| Extreme_Weight-vs-Obese |
2.210400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.138400E-01 |
| Obese-vs-Extreme_Obese |
1.804190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.577990E-01 |
| Normal-vs-Age(41-60Yrs) |
1.74530000000006E-05 |
| Normal-vs-Age(61-80Yrs) |
9.65819646481236E-11 |
| Normal-vs-Age(81-100Yrs) |
8.43759999999971E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.261400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.556100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.616400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.998100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.202600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.249400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.30669985521604E-11 |
| Normal-VS-Type2 PRCC |
8.33380000000439E-05 |
| Normal-VS-KIRP CIMP |
5.517400E-01 |
| Normal-VS-Unclassified PRCC |
1.571530E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.307900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.130500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.467970E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.658000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.848600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.161800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.4499999995431E-07 |
| Normal-vs-N1 |
1.917760E-01 |
| Normal-vs-N2 |
9.457800E-01 |
| N0-vs-N1 |
1.635980E-01 |
| N0-vs-N2 |
5.892200E-02 |
| N1-vs-N2 |
5.528000E-01 |
|
|
